YEGANEH JALAEIAN: Open Payments
NPI 1578957726 · VIENNA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$908 in 10 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $37 · 2025 $908
Food & beverage: $908
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $243 |
| Axsome Therapeutics, Inc. | 2 | $233 |
| Braeburn Inc. | 1 | $109 |
| ABBVIE INC. | 1 | $100 |
| Indivior Inc. | 1 | $100 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $85 |
| Alkermes, Inc. | 2 | $38 |
Products named: Auvelity, REXULTI, ABILIFY MAINTENA, BRIXADI, VRAYLAR, SUBLOCADE, CAPLYTA, VIVITROL.
Industry payments across VA — which companies pay providers there.
